BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23437317)

  • 1. Role of IRAK-M in alcohol induced liver injury.
    Wang Y; Hu Y; Chao C; Yuksel M; Colle I; Flavell RA; Ma Y; Yan H; Wen L
    PLoS One; 2013; 8(2):e57085. PubMed ID: 23437317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.
    Lye E; Dhanji S; Calzascia T; Elford AR; Ohashi PS
    Eur J Immunol; 2008 Mar; 38(3):870-6. PubMed ID: 18286567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice.
    Klimesova K; Kverka M; Zakostelska Z; Hudcovic T; Hrncir T; Stepankova R; Rossmann P; Ridl J; Kostovcik M; Mrazek J; Kopecny J; Kobayashi KS; Tlaskalova-Hogenova H
    Inflamm Bowel Dis; 2013 May; 19(6):1266-77. PubMed ID: 23567778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M.
    Rothschild DE; Zhang Y; Diao N; Lee CK; Chen K; Caswell CC; Slade DJ; Helm RF; LeRoith T; Li L; Allen IC
    EBioMedicine; 2017 Feb; 15():36-47. PubMed ID: 27939424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses.
    Zhang Y; Diao N; Lee CK; Chu HW; Bai L; Li L
    Mol Ther; 2020 Jan; 28(1):89-99. PubMed ID: 31607540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth.
    Xie Q; Gan L; Wang J; Wilson I; Li L
    Mol Immunol; 2007 Jul; 44(14):3453-61. PubMed ID: 17477969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection.
    Oliveira FS; Carvalho NB; Brandão AP; Gomes MT; de Almeida LA; Oliveira SC
    Infect Immun; 2011 Nov; 79(11):4688-95. PubMed ID: 21844234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.
    Standiford TJ; Kuick R; Bhan U; Chen J; Newstead M; Keshamouni VG
    Oncogene; 2011 May; 30(21):2475-84. PubMed ID: 21278795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
    Bagchi AK; Akolkar G; Mandal S; Ayyappan P; Yang X; Singal PK
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1238-H1247. PubMed ID: 28432060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of IL-1 Receptor-Associated Kinase-4 Leads to Defective Th1 Cell Responses and Renders Mice Susceptible to Mycobacterial Infection.
    Marinho FV; Fahel JS; Scanga CA; Gomes MT; Guimarães G; Carvalho GR; Morales SV; Báfica A; Oliveira SC
    J Immunol; 2016 Sep; 197(5):1852-63. PubMed ID: 27439514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts.
    Chen W; Saxena A; Li N; Sun J; Gupta A; Lee DW; Tian Q; Dobaczewski M; Frangogiannis NG
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2598-608. PubMed ID: 22995519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes.
    Julian MW; Strange HR; Ballinger MN; Hotchkiss RS; Papenfuss TL; Crouser ED
    PLoS One; 2015; 10(7):e0132921. PubMed ID: 26218271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction.
    Saxena A; Shinde AV; Haque Z; Wu YJ; Chen W; Su Y; Frangogiannis NG
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):223-31. PubMed ID: 26542797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia.
    Hoogerwerf JJ; van der Windt GJ; Blok DC; Hoogendijk AJ; De Vos AF; van 't Veer C; Florquin S; Kobayashi KS; Flavell RA; van der Poll T
    Mol Med; 2012 Sep; 18(1):1067-75. PubMed ID: 22729155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired T-cell receptor activation in IL-1 receptor-associated kinase-4-deficient patients.
    McDonald DR; Goldman F; Gomez-Duarte OD; Issekutz AC; Kumararatne DS; Doffinger R; Geha RS
    J Allergy Clin Immunol; 2010 Aug; 126(2):332-7, 337.e1-2. PubMed ID: 20621347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.
    Flannery S; Bowie AG
    Biochem Pharmacol; 2010 Dec; 80(12):1981-91. PubMed ID: 20599782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE).
    Liu B; Gu Y; Pei S; Peng Y; Chen J; Pham LV; Shen HY; Zhang J; Wang H
    J Autoimmun; 2019 Aug; 102():77-88. PubMed ID: 31036429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Role of IRAK-M in Regulating Antigen-Induced Airway Inflammation.
    Zhang M; Chen W; Zhou W; Bai Y; Gao J
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):547-559. PubMed ID: 28665693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice.
    Tan Q; Majewska-Szczepanik M; Zhang X; Szczepanik M; Zhou Z; Wong FS; Wen L
    Diabetes; 2014 Aug; 63(8):2761-75. PubMed ID: 24696448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression.
    Peng JH; Cui T; Huang F; Chen L; Zhao Y; Xu L; Xu LL; Feng Q; Hu YY
    J Pharmacol Exp Ther; 2013 Mar; 344(3):646-54. PubMed ID: 23277536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.